High-dose synthetic progestins are effective in the treatment of endometriosis through suppression of luteinizing hormone and FSH secretion that inhibits estradiol production, direct antiestrogenic effects on the lesions, and induction of pseudodecidualization (Taylor and Lebovic 2009). The gene discussed is BRD2; the disease is endometriosis.